Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
InventHelp Inventor Develops Easy Way to Identify Luggage (RSM-209)
-
ISN® to Enhance Contractor Safety and Compliance for Clariant
-
Joker: Folie à Deux (Score from the Original Motion Picture Soundtrack) by Academy Award- & Grammy-winning Composer Hildur Guðnadóttir
-
Acuity Insights named one of Canada's Top Growing Companies by The Globe and Mail Report on Business
-
‘Space Nation Online’ Kicks Off a Grand Post-Earth Adventure in Sept. 27 Soft Launch
-
Elasticsearch Open Inference API and Playground Support Google Cloud’s Vertex AI Platform
-
Acuity Insights named one of Canada's Top Growing Companies by The Globe and Mail Report on Business
-
Information on the shares issued by Rokiskio suris AB and the votes granted
-
Phase 1 clinical trial results support feasibility and safety of administering cell therapy as treatment for people with Parkinson's disease
-
Capitolis Wins World’s Best FX Software Provider in 2024 Euromoney Foreign Exchange Awards
-
AM Best Affirms Credit Ratings of Sompo Japan Insurance Inc. and Its Subsidiaries
-
Provi Enhances Trade Marketing Program with New Leadership Appointment
-
Law Offices of Jason Turchin Investigates Electric Blanket Recalls Following Fire Hazards and Burn Injuries
-
Pacylex Pharmaceuticals Recognized as BioAlberta’s Company of the Year
-
BUYBACK OF RIKSBANK CERTIFICATES
-
Surety One, Inc. Backs The Me Fine Foundation, Strengthening The Families of Critically Ill Children
-
Acceleration of EVIG’s European Rollout: Clean Motion and Valeo Deepen Collaboration at Valeo New Mobility Center in Amiens
-
Cisco and BT Partner To Upskill Ukrainian Refugees in Ireland
-
Vow ASA: Notification of trade – primary insider
-
Safeguard Against Credit Application Fraud with Bectran and Cobalt Integration
-
Rokiskio suris AB acquires own shares
-
CannabisNewsWire is a Gold Sponsor and Official NewsWire for the Grow Up Conference & Expo
-
Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
-
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
-
Fifth Third Named a 2024 Leading Disability Employer by the National Organization on Disability
-
LTIMindtree Strengthens Partnership with Currys
-
Patients for Patient Safety US Applauds the Biden-Harris Administration for Prioritizing Patient Safety
-
How to Partner With Impact Start-Ups for Innovation
-
Social Media Insights: How to Monitor Social Platforms Right
-
GAHL ANNOUNCES STRATEGIC AND FINANCIALLY ACCRETIVE ACQUISITION
-
Barrack, Rodos & Bacine Notifies Shareholders of Methode Electronics (MEI) of a Securities Class Action Lawsuit
-
BetterHelp Partners with Talkiatry to Offer Therapy & Psychiatric Services to Businesses
-
Tachus Fiber Internet Celebrates Achieving 50,000 Customers With Family in Kingwood, Texas
-
Form 8.3 - Rightmove Plc
-
West Oak Announces Option to Acquire the Ptarmigan Silica Project
-
Qifu Technology Responds to Short Seller Report
-
Central Garden & Pet Appoints Niko Lahanas as CEO and Brad Smith as CFO
-
Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular
-
Form 8.3 - Keywords Studios Plc
-
Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3
-
Ensurge Micropower ASA - Registration of Share Capital Increase
-
Invesco Ltd: Form 8.3 - Rightmove PLC ;Public dealing disclosure
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
Global Manufacturer Selects Seraphic Security for Enterprise Browser Security
-
Anti-inflammatory drug shows potential as disease-modifying therapy for Parkinson's disease
-
The Most Hair-Raising Haunted Attractions Announced by America Haunts
-
Jack Nathan Health Announces Its Q2 Fiscal 2025 Financial Results
